A Novel Compound Heterozygous Mutation in ABCB4 Gene Leading to Cholelithiasis, Progressive Familial Intrahepatic Cholestasis (Type 3), and Cirrhosis in a Child

Abstract

Progressive familial intrahepatic cholestasis (PFIC) is a heterogeneous group of autosomal recessive disorders of childhood which presents with intermittent or progressive episodes of cholestasis, with jaundice and pruritus as most common presenting symptoms. PFIC type 3 occurs due to mutations in the ABCB4 gene, mutation in this gene has wide spectrum of features which include intrahepatic stones, cholelithiasis, PFIC type 3, and intrahepatic cholestasis of pregnancy. Here, we are reporting a peculiar case of young male adolescent with novel variant compound heterozygote missense mutation in ABCB4 gene who had gall stone as initial symptom, followed by symptoms of PFIC and eventually decompensated chronic liver disease.

Keywords

gallstone - novel mutation - liver cirrhosis

Publication History

Received: 01 July 2020

Accepted: 22 August 2020

Article published online:
09 October 2020

• References

• 1 Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis 2009; 4: 1
• 2 de Vree JM, Jacquemin E, Sturm E. et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA 1998; 95 (01) 282-287
• 3 Wadsworth CA, Dixon PH, Wong JH. et al. Genetic factors in the pathogenesis of cholangiocarcinoma. Dig Dis 2011; 29 (01) 93-97
• 4 Lammert F, Wang DQ, Hillebrandt S. et al. Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis. Hepatology 2004; 39 (01) 117-128
• 5 Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999; 353 (9148): 210-211
• 6 Rosmorduc O, Hermelin B, Poupon R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001; 120 (06) 1459-1467
• 7 Wu Z, Zhang S, Zhang L, Li M. Novel ABCB4 mutation in a Chinese female patient with progressive familial intrahepatic cholestasis type 3: a case report. Diagn Pathol 2020; 15 (01) 39
• 8 Jacquemin E. Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases. Semin Liver Dis 2001; 21 (04) 551-562
• 9 Jacquemin E, De Vree JM, Cresteil D. et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001; 120 (06) 1448-1458
• 10 Pasmant E, Goussard P, Baranes L. et al. First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis. Eur J Hum Genet 2012; 20 (03) 277-282
• 11 Lucena JF, Herrero JI, Quiroga J. et al. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology 2003; 124 (04) 1037-1042
• 12 Francis FF, Frye R, Hashash JG. Cholelithiasis and biliary cirrhosis in a 28-year-old man. Clin Gastroenterol Hepatol 2017; 15 (05) A31-A32